Inventor · disambiguated record
Robert Joseph Stagg
Also filed as: STAGG ROBERT J · STAGG ROBERT JOSEPH
9 granted patents·6 pending applications·51 citations·filing 2010–2018
87Inventor score
Top patents by PatentIndex Score
15 records- 0189US10870693B2Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agentONCOMED PHARM INC·Filed 2018·Granted Dec 22, 2020·3 cites·22 claims
- 0289US9599620B2Methods and monitoring of treatment with a DLL4 antagonistONCOMED PHARM INC·Filed 2013·Granted Mar 21, 2017·7 cites·21 claims
- 0386US9511139B2Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agentONCOMED PHARM INC·Filed 2014·Granted Dec 6, 2016·8 cites·25 claims
- 0486US8883145B2Methods of treatment with DLL4 antagonists and an anti-hypertensive agentSTAGG ROBERT JOSEPH·Filed 2010·Granted Nov 11, 2014·16 cites·38 claims
- 0583US9359444B2Methods and monitoring of treatment with a Wnt pathway inhibitorONCOMED PHARM INC·Filed 2014·Granted Jun 7, 2016·6 cites·29 claims
- 0683US9266959B2Methods of treating neuroendocrine tumors using frizzled-binding agentsONCOMED PHARM INC·Filed 2013·Granted Feb 23, 2016·6 cites·20 claims
- 0782US9982042B2Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agentONCOMED PHARM INC·Filed 2016·Granted May 29, 2018·3 cites·51 claims
- 0878US11339213B2Methods and compositions for treatment of cancerMEREO BIOPHARMA 5 INC·Filed 2016·Granted May 24, 2022·2 cites·36 claims
- 0959US2017299598A1Methods and Monitoring of Treatment With A DLL4 AntagonistONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 1057US2016334423A1Methods and monitoring of treatment with a dll4 antagonistONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 1155US9987357B2Methods and monitoring of treatment with a WNT pathway inhibitorONCOMED PHARM INC·Filed 2016·Granted Jun 5, 2018·0 cites·20 claims
- 1254US2019000970A1Methods and Monitoring of Treatment with a WNT Pathway InhibitorONCOMED PHARM INC·Filed 2018·Application pending·0 cites
- 1348US2016324961A1Methods for Treating Cancer with DLL4 AntagonistsONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 1446US2013323265A1Methods for treating cancer with dll4 antagonistsSTAGG ROBERT JOSEPH·Filed 2011·Application pending·0 cites
- 1542US2016235844A1Methods of treating neuroendocrine tumors using frizzled-binding agentsONCOMED PHARM INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →